NCT00663884
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- The Catholic Univ. of Korea, Kangnam ST. Mary's Hospital Seoul, South Korea
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
157 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT01013571
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis Administrative Office Laval, Canada
Completed
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
NCT00671424
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Columbus, Ohio, United States
NCT00532610
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- GSK Investigational Site Madison, Wisconsin, United States
NCT00501462
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +11 more
- Locations
-
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Minneapolis, Minnesota, United States
- GSK Investigational Site Knoxville, Tennessee, United States
- GSK Investigational Site Austin, Texas, United States
NCT00931372
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Sanofi-Aventis Administrative Office Berlin, Germany
NCT01263470
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Okayama, Japan
NCT01522807
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Singapore
Completed
The Effect of a Nutritional Supplement in Individuals With Type 2 Diabetes Mellitus: a Pilot Study
NCT01505803
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Dyslipidemias, +11 more
- Locations
-
- University of Sydney Sydney, New South Wales, Australia
Completed
Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast
NCT00664534
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Smiths Falls, Ontario, Canada
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bāb al Lūq, Egypt
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt